# FDA Warns of Kidney Injury Risk with OTC Weight Loss Drug

Canonical: https://brew.new/browse/templates/email/pt1_k97g9x8chgmpwdszqjxc611sbs8e53ch

Brand: doximity.com
Category: newsletter

![Preview of FDA Warns of Kidney Injury Risk with OTC Weight Loss Drug](https://cdn.brew.new/email-preview-2c9336d26356cdd4-tracking_r57s065jsbevwdk0ghwhvg7x1x8dty5m-1789004900364.png)

## Email content

This Week in Internal Medicine News

Curated for

John Pork, MD

U.S. Food and Drug Administration

FDA Warns of Kidney Injury Risk with OTC Weight Loss Drug

Gizmodo

Oh Great, a Parasite That Causes Explosive Diarrhea Is Spreading Right Now

What Your Patients Are ReadingWhat Your Patients Are Reading

Scientific Reports

Do PPIs Raise Risk of Dementia?

American College of Cardiology

Combined LDL-C, Lp(A) and hsCRP Assessment Identifies Long-Term Risk of ASCVD

Harvard Pilgrim Health Care Institute

Federal Efforts to Expand the Physician Workforce Fall Short for Primary Care

British Journal of Sports Medicine

The 'Sweet Spot' For Weight Training and Mortality Benefit

Op-Med

How to Actually Go on Vacation as a Physician

Mayo Clinic Proceedings

Hyponatremia: A Mechanistic Approach to Diagnosis and Management

Full-Text AvailableFull-Text Available

Put Your Knowledge to the Test

57-year-old w/ worsening urinary symptoms. Urinalysis positive for leukocyte esterase, nitrites, and WBCs. Bladder ultrasound shows mild post-void residual urine w/o evidence of obstruction.

Learn More and Solve Case

How useful was this digest?

Very useful / Somewhat / Not useful

Download for

iOS

or

Android.

Doximity.com

• 500 3rd Street, Suite 510 • San Francisco, CA 94107

Unsubscribe from Doximity | Specialty News

•

Terms of Service

•

Privacy Policy

UUID:

59d91abf-7365-47bd-a463-a6e2a112c906

[Open and remix this design](https://brew.new/browse/templates/email/pt1_k97g9x8chgmpwdszqjxc611sbs8e53ch)

[Browse email designs](https://brew.new/browse/templates)